Fenoldopam Mesylate Enhances the Survival of Mesenchymal Stem Cells Under Oxidative Stress and Increases the Therapeutic Function in Acute Kidney Injury

Mesenchymal stem cells (MSCs) have gained interest as an alternative therapeutic option for renal diseases, including acute kidney injury (AKI). However, their use is often limited owing to low survival rates in vivo. Fenoldopam mesylate (FD) is a selective dopamine D1 receptor agonist with antioxid...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Seo Yeon, Cho, Hye Jin, Kim, Tae Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830573/
https://www.ncbi.nlm.nih.gov/pubmed/36594258
http://dx.doi.org/10.1177/09636897221147920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830573/
https://www.ncbi.nlm.nih.gov/pubmed/36594258
http://dx.doi.org/10.1177/09636897221147920

Ejemplares similares